CUL4B and cancer: As expected, downregulation of miR34a was observed in 61% (23/38) of tumor tissues (Supplementary Fig. S4A), while upregulation of CUL4B was observed in 68% (26/38) of cancer tissues (Supplementary Fig. S4B).